Hospital General Universitario Gregorio Marañón-ko ikertzaileekin lankidetzan egindako argitalpenak (20)

2024

  1. Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up study

    European Neuropsychopharmacology, Vol. 85, pp. 66-77

  2. Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study

    Spanish Journal of Psychiatry and Mental Health

2023

  1. Obstetric complications and genetic risk for schizophrenia: Differential role of antenatal and perinatal events in first episode psychosis

    Acta Psychiatrica Scandinavica

  2. Psychosis and substance abuse increase the COVID-19 mortality risk

    Psychological Medicine, Vol. 53, Núm. 9, pp. 4236-4244

2022

  1. Four-month incidence of suicidal thoughts and behaviors among healthcare workers after the first wave of the Spain COVID-19 pandemic

    Journal of Psychiatric Research, Vol. 149, pp. 10-17

  2. NRN1 Gene as a Potential Marker of Early-Onset Schizophrenia: Evidence from Genetic and Neuroimaging Approaches

    International Journal of Molecular Sciences, Vol. 23, Núm. 13

2021

  1. Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis

    Schizophrenia Research, Vol. 236, pp. 19-28

  2. The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis

    Psychopharmacology, Vol. 238, Núm. 3, pp. 665-676

2020

  1. Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs study

    Schizophrenia Research, Vol. 218, pp. 292-294

  2. Influence of social cognition as a mediator between cognitive reserve and psychosocial functioning in patients with first episode psychosis

    Psychological Medicine, Vol. 50, Núm. 16, pp. 2702-2710

2019

  1. Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis

    European Neuropsychopharmacology, Vol. 29, Núm. 6, pp. 786-794

  2. Long-acting injectable antipsychotics for the treatment of schizophrenia in Spain

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 2, pp. 92-105

2018

  1. Cognitive reserve as an outcome predictor: first-episode affective versus non-affective psychosis

    Acta Psychiatrica Scandinavica, Vol. 138, Núm. 5, pp. 441-455

  2. Individual trajectories of cognitive performance in first episode psychosis: a 2-year follow-up study

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 268, Núm. 7, pp. 699-711

  3. Smoking does not impact social and non-social cognition in patients with first episode psychosis

    Schizophrenia Research, Vol. 199, pp. 64-74

2017

  1. Persistent negative symptoms in first-episode psychosis: Early cognitive and social functioning correlates and differences between early and adult onset

    Journal of Clinical Psychiatry, Vol. 78, Núm. 9, pp. 1414-1422

  2. The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study

    Schizophrenia Research, Vol. 189, pp. 84-90

2016

  1. A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project

    International Journal of Neuropsychopharmacology, Vol. 19, Núm. 4

2013

  1. Premorbid impairments in early-onset psychosis: Differences between patients with schizophrenia and bipolar disorder

    Schizophrenia Research, Vol. 146, Núm. 1-3, pp. 103-110

2011

  1. Decreased GABAA and GABAB receptor functional activity in cannabinoid CB1 receptor knockout mice

    Journal of Psychopharmacology, Vol. 25, Núm. 1, pp. 105-110